Research ArticleArticle
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden?
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, Rene Westhovens and Patrick Verschueren
The Journal of Rheumatology November 2020, jrheum.200758; DOI: https://doi.org/10.3899/jrheum.200758
Sofia Pazmino
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Anikó Lovik
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Annelies Boonen
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Diederik De Cock
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Veerle Stouten
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Johan Joly
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Delphine Bertrand
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Kristien Van der Elst
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Rene Westhovens
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
Patrick Verschueren
The CareRA trial (EudraCT number: 2008-007225-39) was funded by a Flemish governmental grant [Agency for Innovation by Science and Technology (IWT)]. S. Pazmino, MD, D. De Cock, PhD, V. Stouten, MSc, D. Bertrand, MSc, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium; A. Lovik, PhD, I-BioStat Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium; A. Boonen, MD, PhD, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; J. Joly, MSc, K. Van der Elst, PhD, Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium; R. Westhovens, MD, PhD, P. Verschueren, MD, PhD, Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, and Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium. PV holds the Pfizer chair for early rheumatoid arthritis management at the KU Leuven. Address correspondence to Dr. S. Pazmino, Division of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: sofia.pazmino@kuleuven.be. Accepted for publication October 27, 2020.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden?
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
The Journal of Rheumatology Nov 2020, jrheum.200758; DOI: 10.3899/jrheum.200758
Does Including Pain, Fatigue, and Physical Function When Assessing Patients with Early Rheumatoid Arthritis Provide a Comprehensive Picture of Disease Burden?
Sofia Pazmino, Anikó Lovik, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
The Journal of Rheumatology Nov 2020, jrheum.200758; DOI: 10.3899/jrheum.200758